FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069939786> ?p ?o ?g. }

• W2069939786 endingPage "2163" @default.
• W2069939786 startingPage "2155" @default.
• W2069939786 abstract "BACKGROUND The role of axillary lymph node dissection (AxD) for patients with breast carcinoma who have clinically negative lymph nodes (cN0) and undergo breast-conserving therapy has been controversial. If patients do not undergo AxD, then it is uncertain whether specific lymph node irradiation should be given. The authors compared the results obtained from patients w ho underwent AxD with the results from patients who received axillary irradiation (AxR) using one of two radiotherapy techniques. METHODS Patients with T1–T2cN0 breast carcinoma were treated from 1983 to 2002 with either AxD (80 patients) or AxR (1134 patients received tangential-field [2-field] irradiation, and 303 patients received 3-field irradiation). The median follow-up was 161 months for the AxD group and 66 months for the AxR group (55 months for patients who received tangential-field irradiation, and 122 months for patients who received 3-field irradiation). RESULTS One patient in the AxD group and 35 patients in the AxR group had axillary recurrences. The 10-year cumulative axillary recurrence rates were 1.3% and 4.6% for the AxD group and the AxR group, respectively (P = 0.21). For patients with T1 tumors, the 10-year overall survival rates for the two groups were 94.7% and 92.7%, respectively (P = 0.34); and, for patients with T2 tumors, the 10-year overall survival rates were 92.5% and 89.1%, respectively (P = 0.34). In the AxR group, the 5-year axillary recurrence rates were 2.5% for patients who received tangential-field irradiation and 1.7% for patients who received 3-field irradiation (P = 0.18), and the 5-year regional recurrence rates for the two groups were 4.8% and 2.4%, respectively (P = 0.048). On multivariate analysis, positive lymphovascular invasion, outer tumor location, and larger tumor size were significant risk factors for regional failure. CONCLUSIONS For patients with cN0 breast carcinoma, AxD and AxR yielded the same overall survival rates. Most patients can be treated safely with tangential-field irradiation alone. Patients who are at increased risk of regional failure may benefit from three-field irradiation. Cancer 2004. © 2004 American Cancer Society." @default.
• W2069939786 created "2016-06-24" @default.
• W2069939786 creator A5005198830 @default.
• W2069939786 creator A5025013177 @default.
• W2069939786 creator A5040121145 @default.
• W2069939786 creator A5046568305 @default.
• W2069939786 creator A5065935505 @default.
• W2069939786 date "2004-01-01" @default.
• W2069939786 modified "2023-09-27" @default.
• W2069939786 title "Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection" @default.
• W2069939786 cites W1492893697 @default.
• W2069939786 cites W1897907766 @default.
• W2069939786 cites W1968263884 @default.
• W2069939786 cites W1977787448 @default.
• W2069939786 cites W1978264082 @default.
• W2069939786 cites W1982655917 @default.
• W2069939786 cites W1987702132 @default.
• W2069939786 cites W1998876800 @default.
• W2069939786 cites W1999220579 @default.
• W2069939786 cites W2006811871 @default.
• W2069939786 cites W2013472456 @default.
• W2069939786 cites W2014069448 @default.
• W2069939786 cites W2015993287 @default.
• W2069939786 cites W2024833142 @default.
• W2069939786 cites W2025679570 @default.
• W2069939786 cites W2029167080 @default.
• W2069939786 cites W2038638262 @default.
• W2069939786 cites W2038660160 @default.
• W2069939786 cites W2039458701 @default.
• W2069939786 cites W2042768010 @default.
• W2069939786 cites W2052986931 @default.
• W2069939786 cites W2063164783 @default.
• W2069939786 cites W2067420088 @default.
• W2069939786 cites W2071793361 @default.
• W2069939786 cites W2073957277 @default.
• W2069939786 cites W2074815465 @default.
• W2069939786 cites W2075083747 @default.
• W2069939786 cites W2079901843 @default.
• W2069939786 cites W2086869132 @default.
• W2069939786 cites W2088932142 @default.
• W2069939786 cites W2097643462 @default.
• W2069939786 cites W2103002013 @default.
• W2069939786 cites W2104472332 @default.
• W2069939786 cites W2123134044 @default.
• W2069939786 cites W2144875053 @default.
• W2069939786 cites W2146679998 @default.
• W2069939786 cites W2148191959 @default.
• W2069939786 cites W267005183 @default.
• W2069939786 cites W2886324946 @default.
• W2069939786 cites W2916529891 @default.
• W2069939786 cites W3157128330 @default.
• W2069939786 cites W4235461667 @default.
• W2069939786 cites W4246299846 @default.
• W2069939786 doi "https://doi.org/10.1002/cncr.20650" @default.
• W2069939786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15476272" @default.
• W2069939786 hasPublicationYear "2004" @default.
• W2069939786 type Work @default.
• W2069939786 sameAs 2069939786 @default.
• W2069939786 citedByCount "14" @default.
• W2069939786 countsByYear W20699397862012 @default.
• W2069939786 countsByYear W20699397862013 @default.
• W2069939786 countsByYear W20699397862014 @default.
• W2069939786 countsByYear W20699397862016 @default.
• W2069939786 crossrefType "journal-article" @default.
• W2069939786 hasAuthorship W2069939786A5005198830 @default.
• W2069939786 hasAuthorship W2069939786A5025013177 @default.
• W2069939786 hasAuthorship W2069939786A5040121145 @default.
• W2069939786 hasAuthorship W2069939786A5046568305 @default.
• W2069939786 hasAuthorship W2069939786A5065935505 @default.
• W2069939786 hasBestOaLocation W20699397861 @default.
• W2069939786 hasConcept C121608353 @default.
• W2069939786 hasConcept C126322002 @default.
• W2069939786 hasConcept C141071460 @default.
• W2069939786 hasConcept C2776608951 @default.
• W2069939786 hasConcept C2777546739 @default.
• W2069939786 hasConcept C2777649267 @default.
• W2069939786 hasConcept C2780212769 @default.
• W2069939786 hasConcept C2780849966 @default.
• W2069939786 hasConcept C2908949552 @default.
• W2069939786 hasConcept C3018521938 @default.
• W2069939786 hasConcept C509974204 @default.
• W2069939786 hasConcept C530470458 @default.
• W2069939786 hasConcept C71924100 @default.
• W2069939786 hasConceptScore W2069939786C121608353 @default.
• W2069939786 hasConceptScore W2069939786C126322002 @default.
• W2069939786 hasConceptScore W2069939786C141071460 @default.
• W2069939786 hasConceptScore W2069939786C2776608951 @default.
• W2069939786 hasConceptScore W2069939786C2777546739 @default.
• W2069939786 hasConceptScore W2069939786C2777649267 @default.
• W2069939786 hasConceptScore W2069939786C2780212769 @default.
• W2069939786 hasConceptScore W2069939786C2780849966 @default.
• W2069939786 hasConceptScore W2069939786C2908949552 @default.
• W2069939786 hasConceptScore W2069939786C3018521938 @default.
• W2069939786 hasConceptScore W2069939786C509974204 @default.
• W2069939786 hasConceptScore W2069939786C530470458 @default.
• W2069939786 hasConceptScore W2069939786C71924100 @default.
• W2069939786 hasIssue "10" @default.
• W2069939786 hasLocation W20699397861 @default.

• next